--- title: Experts Change Their Minds About Prostate Cancer Screening description: In recent years an expert group advised most men not to get screened for prostate cancer. Now they’re leaning toward recommending the test canonical: https://time.com/4733273/prostate-cancer-screening-test/ author: Alice Park article:opinion: false article:content_tier: free article:published_time: 2017-04-11T14:50:45.000Z article:modified_time: 2026-10-08T08:45:10.040Z article:section: Health og:title: Experts Change Their Minds About Prostate Cancer Screening og:description: In a reversal, an expert group is now recommending the test og:url: https://time.com/4733273/prostate-cancer-screening-test/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt11e539440670afa3/6988c135ab6d7793a76ad785/time-health-stock-first-air-kit.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 og:image:width: 5000 og:image:height: 2813 og:image:alt: time-health-stock og:type: article twitter:card: summary_large_image twitter:title: Experts Change Their Minds About Prostate Cancer Screening twitter:description: In a reversal, an expert group is now recommending the test twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt11e539440670afa3/6988c135ab6d7793a76ad785/time-health-stock-first-air-kit.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 ---  # Experts Change Their Minds About Prostate Cancer Screening > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: September 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=cc75a3a9-95c3-4c05-874c-7f4eb0e5e1f3&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | | Health Matters | The latest health news and expert advice on living well | Weekdays | | Worth Your Time | A weekly guide to what to watch, read, and more | Weekly | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Twice a week | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | Source: TIME, August 2026. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=cc75a3a9-95c3-4c05-874c-7f4eb0e5e1f3&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=cc75a3a9-95c3-4c05-874c-7f4eb0e5e1f3&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement. ### Sources * TIME Newsletters: [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=cc75a3a9-95c3-4c05-874c-7f4eb0e5e1f3&cr=time-nl-network-2026q3-v1) ## Video: Experts Change Their Minds About Prostate Cancer Screening [Watch (HLS stream): Experts Change Their Minds About Prostate Cancer Screening](https://cdn.jwplayer.com/manifests/ehiZedWA.m3u8) (1:01)  _Published 2017-04-12. An influential government health task force now says that the benefits of getting screened for prostate cancer may slightly outweigh the risks_  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Apr 11, 2017 2:50 PM UTC An influential government health task force now says that the benefits of getting screened for prostate cancer may slightly outweigh the risks  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Apr 11, 2017 2:50 PM UTC An influential health task force convened by the government [now says](https://screeningforprostatecancer.org/) that the benefits of getting screened for prostate cancer may slightly outweigh the risks. For that reason, the U.S Preventive Services Task Force (USPSTF) is advising men to discuss with their doctors whether screening makes sense for them, rather than skipping the test as they’d previously recommended for most men. The new recommendation is a reversal from the one they issued in 2012, when the USPSTF advised most men [not to get screened for prostate cancer](http://healthland.time.com/2012/05/22/men-should-forgo-psa-testing-for-prostate-cancer-panel-advises/?iid=sr-link1) using an inexpensive blood test, called a prostate specific antigen (PSA) test. Based on the evidence they had available at that time, they concluded that the risks of screening—which include false positive results, overtreatment of slow-growing cancers and side effects from those treatments—outweighed the small benefits. But with more data on the subject, the task force now leans toward the benefits of screening. It’s particularly challenging to know whether a man should be screened and even treated for prostate cancer. When it appears in middle-aged men, it frequently develops so slowly that it’s rarely the cause of death, so treating it with invasive and toxic therapies like surgery, chemotherapy and radiation often exposes men to more side effects and harms without protecting them from dying from that cancer. “We had evidence in 2012 that suggested to us the benefits of screening did not outweigh the harms,” says Dr. Kirsten Bibbins-Domingo, chair of the USPSTF and professor of medicine at University of California San Francisco. “That’s why we recommended against screening. With this update we have new evidence and our assessment of the balance shifted to now say there is likely a small net benefit to screening.” The task force analyzed new data from two large studies of prostate cancer screening, one based in Europe and the other in the U.S. The European study, with more than a decade of follow-up, found that men who received blood test screening every two to four years with the PSA test lowered their risk of dying from prostate cancer during the study by an average of 20%. Even more encouraging, the men who were screened had a 30% lower chance of developing metastatic prostate cancer if they did develop the disease. “These results give us confidence that we really have the full picture of the potential benefits of screening,” says Bibbins-Domingo. In the U.S. study, researchers compared outcomes for men who were screened and decided not to immediately treat their cancer, a practice called active surveillance. Instead of subjecting themselves to the potential harms of biopsies and treatment, they instead worked with their doctors to receive more regular checkups and monitoring of their cancer and only started treatment if the tumors developed. Men who chose to do this did not die sooner than men who received immediate treatment, the study found. That’s good news, because in the U.S., more men are opting for active surveillance. Even if they were to get regular PSA screening, they wouldn’t necessarily be exposed to as many harms from treatment. “The harms of prostate cancer screening are very important, but now we have strategies to help mitigate them,” says Bibbins-Domingo. “That allows us to say that there is likely overall a small net benefit to screening.” The revised advice isn’t a wholesale endorsement of PSA screening for all men. The task force continues to stress that the decision to screen or not is an individual one, and one that each man should discuss with his doctor. “The most important thing is for doctors and patients together to have a conversation,” says Bibbins-Domingo, “so that men can make the best decision for themselves.” ## Transcript [00:38] [ MUSIC ] ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/4733273/prostate-cancer-screening-test/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/4733273/prostate-cancer-screening-test/"},"headline":"Experts Change Their Minds About Prostate Cancer Screening","datePublished":"2017-04-11T14:50:45.000Z","dateModified":"2026-10-08T08:45:10.040Z","description":"In recent years an expert group advised most men not to get screened for prostate cancer. Now they’re leaning toward recommending the test","url":"https://time.com/4733273/prostate-cancer-screening-test/","keywords":["Cancer","prostate cancer","psa"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt11e539440670afa3/6988c135ab6d7793a76ad785/time-health-stock-first-air-kit.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Alice Park","jobTitle":"Senior Correspondent","url":"https://time.com/author/alice-park/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt11e539440670afa3/6988c135ab6d7793a76ad785/time-health-stock-first-air-kit.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"time-health-stock","caption":"First aid kit standing on a blue and white background TIME health stock","creditText":"Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://time.com/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"https://time.com/tag/cancer/","name":"Cancer"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/4733273/prostate-cancer-screening-test/","name":"Experts Change Their Minds About Prostate Cancer Screening"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"Experts Change Their Minds About Prostate Cancer Screening","description":"An influential government health task force now says that the benefits of getting screened for prostate cancer may slightly outweigh the risks","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/ehiZedWA/poster.jpg?width=720","uploadDate":"2017-04-12T17:46:36.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/ehiZedWA.m3u8","embedUrl":"https://time.com/4733273/prostate-cancer-screening-test/","duration":"PT1M1S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/4733273/prostate-cancer-screening-test/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}] ```